The Center for Business Intelligence (CBI) will be holding its 3rd Summit on Biosimilars and Follow-on Biologics on September 14-15, 2009 in National Harbor, MD. The conference will address the multiple competing follow-on biologics bills that have been introduced in the current Congress and the impact of this legislation on the life sciences industry. CBI's faculty will offer presentations on the following topics:
• Policy update and analysis;
• Pathway for the Biosimilars Act (H.R. 1548 introduced by Rep. Anna Eshoo);
• Promoting Innovation and Access to Life-Saving Medicines Act (H.R. 1427 introduced by Rep. Henry Waxman);
• Explore the political principles, expectations and implications of pending biosimilars legislation;
• Analyze patient safety concerns and biologic/biosimilar comparability;
• Regulatory mechanisms, considerations and implications of biosimilar policy;
• Review antitrust provisions and lessons learned from Hatch-Waxman;
• Assess antitrust concerns and the competitive impact of biosimilars;
• Identify the commercial, economic and strategic implications of biosimilars -- Analyze the biotech and biosimilars markets;
• Biotech market analysis;
• Biosimilars market analysis;
• Biosimilars versus biobetters -- A side-by-side strategic analysis;
• Understand the reimbursement and benefit implications for biosimilars;
• Healthcare policy and payment perspective -- Reimbursement payment system and benefit design implications;
• Examine patent dispute mechanisms, IP issues and litigation concerns;
• Analyze the methods of patent dispute and resolution in pending legislation;
• Current and future IP challenges for biogenerics players -- A global perspective; and
• A change in the patent litigation dynamic -- Will "big pharma" become "big generic"?
A complete agenda for the Summit on Biosimilars and Follow-on Biologics can be found here (Day One) and here (Day Two). A brochure for this conference can be requested here.
The registration fee for the conference is $2,095. Attendees registering on or before July 17, 2009 will receive a $400 discount off the registration fee, and attendees registering a group of three individuals will receive a fourth registration for free. Those interested in registering for the conference can do so here, by calling 1-800-817-8601, or by e-mail at [email protected].
Patent Docs is a media partner of CBI's Summit on Biosimilars and Follow-on Biologics.
Comments